Nada Alachkar is a Nephrology physician affiliated with Johns Hopkins University. OpenAlex indexes 103 publications with 5,697 citations (h-index 32).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 N Wolfe St
Brady 505
Baltimore, MD 212870005
Telephone
410-955-5029Registry record last updated 3 Mar 2015.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Ardelyx, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
53.3%Calcium channel blocker13.9%Amlodipine Besylate73%Nifedipine Er27%Part D≥41 patientsStatin12.5%Atorvastatin Calcium72%Rosuvastatin Calcium15%Pravastatin Sodium13%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
29%Corticosteroid15.9%Prednisone100%Part D≥55 patientsProton pump inhibitor7.6%Pantoprazole Sodium84%Omeprazole16%Part D<11 patients+ 3 more classes in this area
Genitourinary & hormones
5.7%alpha-Adrenergic Blocker5.7%Tamsulosin Hcl100%Part D≥22 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Banff 2022 Kidney Meeting Work Plan: Data-driven refinement of the Banff Classification for renal allografts
American Journal of Transplantation
2023 - Immune-mediated entities of (primary) focal segmental glomerulosclerosis
Cell and Tissue Research
2021 - The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
American Journal of Transplantation
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Roger Blumenthal, MD
Johns Hopkins University
Erin Michos, MD
Johns Hopkins University
Morgan Grams, MD
Johns Hopkins University
Mario Eisenberger, MD
Johns Hopkins University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”